- At this time, masks are only required for patients over 2 years of age who have respiratory symptoms, have a potentially contagious condition or have fever
- If you or your child are Covid-19 positive or suspected Covid-19 positive, please let us know and we will provide you with instructions on our safety procedures before your appointment and schedule your child appropriately – please wear a mask in our office to protect the other patients
- If you or your child are on isolation and have a scheduled appointment, please call us to reschedule to an appropriate time or take necessary safety precautions for our staff and patients
CDC ISOLATION GUIDELINES :
FOR A POSITIVE TEST:
- Masks and infection control are recommended for 5 days from the start of symptoms if you test positive – you are likely most infectious during this time
- If you have no symptoms or your symptoms are resolving after 24hrs and you have been fever free for 24 hours, you may end isolation, but it is still recommended that you wear a mask so as not to transmit the virus
- You may test out of the infectious period of 5 days by doing an at home rapid test and not require a mask
- If you are immunocompromised or if you have had moderate or severe illness and continue to test positive on a rapid home test with symptoms, you must isolate for your symptomatic time
FOR EXPOSURE:
Regardless of vaccination status…
- If you stay asymptomatic and have a negative test days 3-5, you are clear
- If you develop symptoms, test immediately or by day 3-5
Oral Covid treatment guidelines (Paxlovid):
o Patients ages 12 and over that weigh 40 kg or more
o Patients who test positive for COVID-19
o Patients who are within 5 days of the onset of symptoms
o Patients who have mild to moderate symptoms
AND
o do not require hospitalization
o are at risk for progression to severe disease based on underlying conditions
- It is taken as 3 pills twice a day for five days
* The full course is required to achieve the benefit of the medication
Local Health Department Links:
Covid-19 Vaccinations:
CDC has updated its guidance for COVID-19 vaccination, including:
Recommendations for use of the 2023–2024 formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine:
- Everyone ages 5 years and older is recommended to receive 1 dose of updated (2023–2024 Formula) mRNA COVID-19 vaccine
- Children ages 6 months–4 years
- Initial vaccination: should receive either 2 doses of updated (2023–2024 Formula) Moderna or 3 doses of updated (2023–2024 Formula) Pfizer-BioNTech COVID-19 vaccine.
- Received previous mRNA doses: need 1 or 2 doses of updated (2023–2024 Formula) Moderna or updated (2023–2024 Formula) Pfizer-BioNTech COVID-19 vaccine, depending on the number of prior doses.
- People who are moderately or severely immunocompromised
- Initial vaccination: should receive a 3-dose series of updated (2023–2024 Formula) Moderna or updated (2023–2024 Formula) Pfizer-BioNTech COVID-19 vaccine.
- Received previous mRNA doses: need 1 or 2 doses of updated (2023–2024 Formula) Moderna or updated (2023–2024 Formula) Pfizer-BioNTech COVID-19 vaccine, depending on the number of prior doses.
- May receive 1 or more additional updated (2023–2024 Formula) mRNA COVID-19 vaccine doses.
- Bivalent mRNA COVID-19 vaccines are no longer recommended in the United States.
